Milwaukee Institute for Drug Discovery
Therapeutic Approaches: Biologics, Small Molecules
Therapeutic Areas of Expertise: Immunology, Infectious Diseases, Neurological Disorders, Oncology, Psychiatric Disorders, Pain
Center/Program Highlights:The Milwaukee Institute for Drug Discovery (MIDD) was established to advance research and later-stage development of new drugs from research at the University of Wisconsin-Milwaukee and collaborating institutions. The Institute will focus on several areas of research strength at UWM; with initiatives in neuroscience, cancer, and infectious diseases. Because of the cross-functional nature of drug discovery and development, the MIDD is focused on collaborations among UWM departments, regional and national academic centers, and medical product companies.
Sources of Funding: Federal/State, Philanthropy, Industry Partnerships, University
Institutional Affiliation(s): University of Wisconsin-Milwaukee
Address:
PO Box 413
Milwaukee
Wisconsin, 53201-0413
United States
Center/Program Start Date: 2010
Number of Employees: 15
